Type of information: Resignation
Compound: chief medical officer
Company: Editas Medicine (USA - MA)
Therapeutic area: Rare diseases - Genetic diseases - Ophtalmological diseases
Type agreement: resignation
- • On August 27, 2018, Editas Medicine announced that its Chief Medical Officer, Gerald Cox will be stepping down from the company at the end of the year. A search is underway to find a successor to Dr. Cox, and the company continues to execute on its near-term and long-term goals of advancing transformative genomic medicines.